Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pierce

Showing results (541-550 of 548) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 548 results.
The New England Journal of Medicine|December 6, 2013
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia BJerry S Powell, K John Pasi, Margaret V Ragni, et al.
Nature Medicine|February 14, 2006
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune responseCatherine S Manno, Glenn F Pierce, Valder R Arruda, et al.
Expert Review of Hematology|March 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and fundingMargaret V Ragni, Guy Young, Glaivy Batsuli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2018
FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based ChemotherapyGwynn Ison, Lynn J Howie, Laleh Amiri-Kordestani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2021
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast CancerMelanie Royce, Christy L Osgood, Anup K Amatya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2025
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Stage II and III High-Risk Early Breast Cancer Treatment SettingJennifer J Gao, Tatiana M Prowell, Haley Gittleman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 6, 2024
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical AppraisalManuela Albisetti, Jesús Ardila, Jan Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 9, 2024
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand DiseaseMark W Skinner, Manuela Albisetti, Jesús Ardila, et al.
Pageof 55

Showing results (541-550 of 548) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 548 results.
The New England Journal of Medicine|December 6, 2013
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia BJerry S Powell, K John Pasi, Margaret V Ragni, et al.
Nature Medicine|February 14, 2006
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune responseCatherine S Manno, Glenn F Pierce, Valder R Arruda, et al.
Expert Review of Hematology|March 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and fundingMargaret V Ragni, Guy Young, Glaivy Batsuli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2018
FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based ChemotherapyGwynn Ison, Lynn J Howie, Laleh Amiri-Kordestani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2021
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast CancerMelanie Royce, Christy L Osgood, Anup K Amatya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2025
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Stage II and III High-Risk Early Breast Cancer Treatment SettingJennifer J Gao, Tatiana M Prowell, Haley Gittleman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 6, 2024
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical AppraisalManuela Albisetti, Jesús Ardila, Jan Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 9, 2024
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand DiseaseMark W Skinner, Manuela Albisetti, Jesús Ardila, et al.
Pageof 55